BUY Aurobindo Pharma — Axis Securities, 28 May 2025

byAxis SecuritiesHorizon: NA (inferred 1 year)28 May 2025via Institutional / Brokerage Research

Entry₹1,147.8Inferred

Target₹1,500

Stop lossNot given

Exit₹1,5008 May 2026, 12:05 pm

Target hit+30.68%0.00%upside left

Follow Axis Securities for new calls(70% target hit, 854 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 10 active Long-term calls on AUROPHARMA

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 4:55 am IST

1 supporting1 neutral0 opposing

Supports the BUY call (1)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 1mo ago

Neutral / worth noting (1)

Aurobindo Pharma Ltd submitted a Letter of Offer for the buyback of 5,423,728 fully paid-up equity shares.

BSE · Company Update·21 Apr · 2w ago

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.